Bristol-Myers grabs EU approval of key melanoma drug - FierceBiotech

Links shared publicly online about this topic.

  • 147
    total visits

Bristol-Myers grabs EU approval of key melanoma drug - FierceBiotech

fiercebiotech.com —

As expected, the European Commission has approved Bristol-Myers Squibb's ($BMY) immunotherapy called Yervoy (ipilimumab) for melanoma that spreads to internal organs. And the company's European chief Read more...

View full resource at fiercebiotech.com

Tags: Cancer, Skin Cancer, Melanoma, Drug, Bristol-Myers Squibb

  • Share

Most Recently Shared on July 14, 2011 at 2:37 pm By:

MelanomaReAlli Melanoma Research

European Commission has approved Yervoy (ipilimumab) for metastatic melanoma: http://bit.ly/qVjIuT

11 months ago...

Reply

Retweet

Favorite

Also Shared By:

FierceBiotech FierceBiotech

Advertisement